InsiderClue
Insiders · Profile

Boyle Scott N

Chief Business Officer at C4 Therapeutics. Filing since 14 Feb 2025. CIK 0001913897

Company
Date
Role
Action
Shares
Amount
Of holding
CCCC C4 Therapeutics, Inc.
18 Feb 2025
Chief Business Officer
Sold on a plan
669
$2.11K
0.6%
CCCC C4 Therapeutics, Inc.
14 Feb 2025
Chief Business Officer
Sold on a plan
490
$1.54K
0.4%
2 decisions on file.